user avatar
LifeArc
@lifearc1
Self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections.
Stevenage, London, Edinburgh
Joined February 2009
Posts
  • user avatar
    We're launching 4 Translational Centres for Rare Diseases! 1️⃣ Centre for Rare Respiratory Diseases 2️⃣ LifeArc @Kidney_Research Centre for Rare Kidney Diseases 3️⃣ Centre for Rare Mitochondrial Diseases 4️⃣ Centre for Acceleration of Rare Disease Trials @MDUK_News @4Lilyfoundation
    00:00
  • user avatar
    Today, we launch a £10M fund for the identification of therapeutics that can be rapidly deployed to treat #COVID-19. Apply for #funding & read more here: bit.ly/2vFklEO
  • user avatar
    📢 Breaking news! £1m awarded for cutting-edge #MND therapies LifeArc, @mndassoc and @MNDoddie5 have teamed up to fund @UCL researchers to progress the development of two pioneering #MotorNeuronDisease cell and gene therapy treatments. Read more➡️bit.ly/3wqNsY1
    Breaking news! £1m awarded for cutting-edge MND therapies.
  • user avatar
    We've received US$1.3bn for royalty interests from work on the #cancerimmunotherapy pembrolizumab. We'll use these funds to advance promising research into health interventions. Learn more: bit.ly/2Ekn4EN #collaboration #translationalresearch #bench-to-bedside
  • user avatar
    LifeArc is proud to announce its pledge to match the fantastic #fundraising efforts of @Leedsrhinos Director of Rugby, #KevinSinfield for @mndassoc, creating a £1m fund to stimulate #research into practical #treatments. Learn more here➡️ bit.ly/2R7jzLs
  • user avatar
    📢£4.25m #ResearchGrant awarded to kick start collaborative efforts to end #MND. LifeArc, alongside charities, patients, researchers & government research orgs, will support #medicalrearch at 6 UK unis to discover MND treatments. ➡️bit.ly/3zQMY0m #MNDAwarenessDay
    00:00
  • user avatar
    📢 Today we launch our new £100m programme to urgently develop new #healthcare solutions for the more than 300,000 people living with #bronchiectasis and #cysticfibrosis in the UK – and many more worldwide 🧵
    📢 Today we launch our new £100m programme to urgently develop new #healthcare solutions for the more than 300,000 people living with #bronchiectasis and #cysticfibrosis in the UK – and many more worldwide.
  • user avatar
    Announcing three new Gene Therapy Innovation Hubs - recipients of £18m joint funding with @The_MRC & @BBSRC to advance new genetic treatments with potential to transform care for millions of patients including those with #RareDisease (1/5) bit.ly/38RBuvs
  • user avatar
    🎬Watch "Turning the Tide" a groundbreaking MND documentary by @UCL: bit.ly/3QpBQOw Their gene therapy offers a promising treatment for MND. bit.ly/479GVC2 #TurningtheTide #MND
    00:00
  • user avatar
    Another step forward for MND research today as the @UKMNDRI launches! It's amazing to be among so many inspirational people to celebrate the Institute and its plans to accelerate the search for an MND cure. 🔗Read about the Institute and our involvement: lifearc.org/news/2023/mnd-…
  • user avatar
    That's a wrap on #LATSS2024! Seeing over 700 scientists, experts, policy makers and innovators together discussing translation and life sciences has been incredible. Thanks to all who attended and we look forward to seeing you again next year.
  • user avatar
    We're delighted to announce the appointment of Dr @SamBarrell1 CBE as our new Chief Executive Officer. She’ll join LifeArc as CEO on 1 October 2024. bit.ly/4d6Z7zi
  • user avatar
    Congratulations to our Translational Challenge leader, Catherine Kettleborough, on being awarded the prestigious Honorary Fellowship by the @BritPharmSoc. This achievement is a testament to Catherine's impactful contributions to life science. bps.ac.uk/news/articles/…
    An image of our Translational Challenge leader, Catherine Kettleborough - celebrating her being awarded the prestigious Honorary Fellowship by the @BritPharmSoc.
  • user avatar
    📢 LifeArc commits £30M to a partnership with @UKDRI. The funding will be used to translate scientific discoveries into new diagnostic tests, treatments and devices to benefit people with #dementia, which affects around 900,000 people in the UK today. ➡️bit.ly/3Hpirsa
    Dr David Powell, Cheif Scientific Officer, LifeArc.

“Great strides have been made in dementia research in recent years but there is much more that needs to be done. We now have huge opportunity to translate this knowledge into new ways to help patients. This partnership will speed up the development of life changing treatments and inspire us all to be bold and do more to help people affected by this condition."